Litcius/Paper detail

SiNiSan ameliorates depression-like behavior in rats by enhancing synaptic plasticity via the CaSR-PKC-ERK signaling pathway

Chongkun Shen, Kerun Cao, Sainan Cui, Yongfei Cui, Haixin Mo, Wenhao Wen, Zhaoyang Dong, Huiyuan Lin, Shasha Bai, Lei Yang, Rong Zhang, Yafei Shi

2020Biomedicine & Pharmacotherapy69 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Adverse stress in early life negatively influences psychiatric health by increasing the risk of developing depression and suicide in adulthood. Clinical antidepressants, such as fluoxetine, exhibit unsatisfactory results due to their low efficacy or intolerable side effects. SiNiSan (SNS), a traditional Chinese herbal formula, has been proven to have affirmatory antidepressive effects. However, the underlying mechanism remains poorly understood. Therefore, this study aimed to explore the impact and molecular mechanism of SNS treatment in rats exposed to neonatal maternal separation (MS)-combined young-adult chronic unpredictable mild stress (CUMS). METHOD: O, positive (fluoxetine: 5 mg/kg), SNS-low dose (2.5 g/kg), SNS-medium dose (5 g/kg), and SNS-high dose (10 g/kg). Behavioral tests included sucrose preference test, open-field test, and forced swimming test. Calcium sensitive receptor (CaSR), protein kinase C (PKC), ERK1/2, and synapse-associated proteins (PSD-95, GAP-43, and synaptophysin [Syn]) in the hippocampus (HIP) and prefrontal cortex (PFC) were assayed using Western blot. CaSR and Syn protein expression was measured by immunohistochemistry. RESULTS: in the HIP and PFC decreased in stressed rats. SNS treatment significantly upregulated the expression of CaSR, PKC, and p-ERK1/2 in the HIP and PFC of adult stressed rats. CONCLUSION: MS-combined CUMS could develop depression-like behavior in adult. SNS exhibited antidepressive effects accompanied by improving synaptic plasticity by activation of the CaSR-PKC-ERK signaling pathway.

Topics & Concepts

SynaptophysinBehavioural despair testPrefrontal cortexEndocrinologyHippocampusFluoxetineInternal medicineOpen fieldAntidepressantMedicineMAPK/ERK pathwaySynaptic plasticityReceptorKinaseImmunohistochemistryChemistryPsychiatrySerotoninBiochemistryCognitionStress Responses and CortisolTryptophan and brain disordersTreatment of Major Depression